Analysis of relationships between solid-state properties, counterion, and developability of pharmaceutical salts. - Wikidata - awgldk - TriplyDB

Analysis of relationships between solid-state properties, counterion, and developability of pharmaceutical salts.

Analysis of relationships between solid-state properties, counterion, and developability of pharmaceutical salts.

http://www.wikidata.org/entity/Q41863073

about

The delivery of arbidol by salt engineering: synthesis, physicochemical properties and pharmacokinetics.Effect of counterions on physicochemical properties of prazosin salts.Investigation of the atypical glass transition and recrystallization behavior of amorphous prazosin salts.Salt stability--effect of particle size, relative humidity, temperature and composition on salt to free base conversion.In-depth investigation on physicochemical and thermal properties of magnesium (II) gluconate using spectroscopic and thermoanalytical techniques.Salt Stability - The Effect of pHmax on Salt to Free Base Conversion.Stability of pharmaceutical salts in solid oral dosage forms.Impact of the counterion on the solubility and physicochemical properties of salts of carboxylic acid drugs.

P2860

Q36105894-1C2FB458-1325-48F5-A19C-0FB774B723F8 Q36636531-AD61E531-01AE-4EE6-8FC8-7C264FE0E05A Q37378153-3E7A6869-8959-4436-8DBC-E54CEABA3207 Q47441074-0A7557E9-5F71-427C-B713-67BE7262802A Q49377546-83422BDD-3279-4219-8C88-2FEB39215D57 Q50931533-5A09CEFF-4B4E-4324-93D9-10129C2B7A1A Q50968375-5A9D7536-588A-4C64-A112-5515E36FCF32 Q53396825-59C1947D-CBC3-46B6-A61A-95EB6890DD7C

P2860

Analysis of relationships between solid-state properties, counterion, and developability of pharmaceutical salts.

http://www.wikidata.org/entity/Q41863073

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Analysis of relationships betw ...... ility of pharmaceutical salts.

@en

type

label

Analysis of relationships betw ...... ility of pharmaceutical salts.

@en

prefLabel

Analysis of relationships betw ...... ility of pharmaceutical salts.

@en

P1433

Q41863073-64652C23-091B-46C9-AFFD-2CB86CDAAB7B

P1476

Q41863073-AAF3E740-454D-4DA9-8111-5D60FFAC7077

P2093

Q41863073-7765CDAF-F176-4DCE-B4D6-96881DDA4BB8

Q41863073-B71D6772-D901-4A43-9BD4-5D313AB953E7

Q41863073-B9E24322-3522-4814-A8B0-EC49B86FE701

Q41863073-FFADE945-1011-472B-B7B8-7204AB4A44D3

P2860

Q41863073-01E95810-AE86-4B9F-9A98-9EF70D070C42

Q41863073-0A60DACB-27F6-4CE9-8B28-2EB1B39779F7

Q41863073-0DB61A36-A2C9-4324-A549-D4BB5D2C00DA

Q41863073-1851CCAD-C431-4CFF-B5C6-416FDF41BBA0

Q41863073-231F73C9-563B-42FE-B44B-765A09F55E0B

Q41863073-23C49FB3-99A6-4A19-AEA9-049A84596D28

Q41863073-24E23E93-2ECE-4018-B625-501186D1BE12

Q41863073-2508EBAA-DCDC-4E30-AE05-1F417099CB98

Q41863073-26DA899E-20F5-45DB-8E2C-E9B40DA89625

Q41863073-2BE89815-6EE0-411A-8A47-835D0E994EBD

P2888

Q41863073-5F7ABAC8-1172-4FD0-9C99-6D4C4522EA99

P304

Q41863073-ABE47267-FE29-45BE-8FBE-3EB96E1536B4

P31

Q41863073-E7605AE9-54EC-45C7-AE39-1EC8BF5A0805

P356

Q41863073-0C66A991-B97C-4454-AD7F-1F6C62EBDB94

P407

Q41863073-C94EB4F5-3E05-421C-9D8C-4869B4E2C0B0

P433

Q41863073-6DF3B351-E589-4946-A699-80813BC81A6A

P478

Q41863073-C9DE1181-7DCD-4D8B-B129-64F2157F9010

P577

Q41863073-0F797EC5-83C0-4DDE-AA2F-D25D44D1D4FE

P5875

Q41863073-A5F5AD71-2AE7-4C42-A443-E981B58E0212

P6179

Q41863073-8CDA89B1-12EC-465E-86C0-1FAE22A1BA8E

P698

Q41863073-9EF06A72-8593-4A87-953F-C107B5AEFD4B

P932

Q41863073-5BD82AC3-6E4E-42E2-8461-745634735C23

P356

S12249-010-9499-4

P1433

AAPS PharmSciTech

P1476

Analysis of relationships betw ...... ility of pharmaceutical salts.

@en

P2093

Alfred C F Rumondor

http://www.w3.org/2001/XMLSchema#string

Lynne S Taylor

http://www.w3.org/2001/XMLSchema#string

Peter Guerrieri

http://www.w3.org/2001/XMLSchema#string

Tonglei Li

http://www.w3.org/2001/XMLSchema#string

P2860

pH-solubility profiles or organic carboxylic acids and their salts

Enhancement of solubility of drug salts by hydrophilic counterions: properties of organic salts of an antimalarial drug

Estimation of aqueous solubility of organic compounds with QSPR approach.

Prediction of drug solubility from structure.

Correlation of aqueous solubility of salts of benzylamine with experimentally and theoretically derived parameters. A multivariate data analysis approach.

An automated approach to salt selection for new unique trazodone salts.

Crystalline solids.

Amorphous pharmaceutical solids: preparation, characterization and stabilization.

Crystal structures of drugs: advances in determination, prediction and engineering.

Impact of solid state properties on developability assessment of drug candidates.

P2888

s12249-010-9499-4

P304

1212-1222

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1208/S12249-010-9499-4

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2010-08-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45462838

http://www.w3.org/2001/XMLSchema#string

P6179

1006292909

http://www.w3.org/2001/XMLSchema#string

P698

20680707

http://www.w3.org/2001/XMLSchema#string

P932

2974123

http://www.w3.org/2001/XMLSchema#string